Regeneron Pharmaceuticals

REGN

HealthcareNMS$79.2B

REGN SEC filings last scanned 4 Oct 2026, 19:23 UTC

CEO Timeline

Leonard Schleifer, M.D., Ph.D.Current

CEO since at least Mar 2005 (no leadership change found in filings)